Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Connors

Showing results (101-110 of 977) with videos related to

Pageof 98
Sort By:
Thrombosis Research|October 10, 2022
Vaccine-induced immune thrombotic thrombocytopenia and patients with cancerJean M Connors, Toshiaki Iba
Seminars in Hematology|April 1, 1987
Updated clinical experience with MACOP-BP Klimo, J M Connors
Seminars in Hematology|April 1, 1987
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's diseaseJ M Connors, P Klimo
Hematology/Oncology Clinics of North America|October 23, 1997
Treatment considerations in the elderly patient with lymphomaJ M Connors, S E O'Reilly
The American Journal of Physiology|March 1, 1981
Feedback regulation of thyrotropin by thyroxine under physiological conditionsJ M Connors, G A Hedge
Journal of Oncology Practice|November 11, 2017
Anticoagulation and Enzalutamide: Caution Over ConvenienceHanny Al-Samkari, Jean M Connors
Clinical Lymphoma & Myeloma|November 15, 2006
Treatment of diffuse large B-cell lymphoma: a risk-based approachLaurie H Sehn, Joseph M Connors
Cancer Treatment Reports|September 1, 1984
Phase I study of weekly high-dose human lymphoblastoid interferonJ M Connors, H K Silver
Blood|April 28, 2020
COVID-19 and its implications for thrombosis and anticoagulationJean M Connors, Jerrold H Levy
The New England Journal of Medicine|August 26, 2021
Heparin Resistance - Clinical Perspectives and Management StrategiesJerrold H Levy, Jean M Connors
Pageof 98

Showing results (101-110 of 977) with videos related to

Sort By:
Pageof 98
Thrombosis Research|October 10, 2022
Vaccine-induced immune thrombotic thrombocytopenia and patients with cancerJean M Connors, Toshiaki Iba
Seminars in Hematology|April 1, 1987
Updated clinical experience with MACOP-BP Klimo, J M Connors
Seminars in Hematology|April 1, 1987
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's diseaseJ M Connors, P Klimo
Hematology/Oncology Clinics of North America|October 23, 1997
Treatment considerations in the elderly patient with lymphomaJ M Connors, S E O'Reilly
The American Journal of Physiology|March 1, 1981
Feedback regulation of thyrotropin by thyroxine under physiological conditionsJ M Connors, G A Hedge
Journal of Oncology Practice|November 11, 2017
Anticoagulation and Enzalutamide: Caution Over ConvenienceHanny Al-Samkari, Jean M Connors
Clinical Lymphoma & Myeloma|November 15, 2006
Treatment of diffuse large B-cell lymphoma: a risk-based approachLaurie H Sehn, Joseph M Connors
Cancer Treatment Reports|September 1, 1984
Phase I study of weekly high-dose human lymphoblastoid interferonJ M Connors, H K Silver
Blood|April 28, 2020
COVID-19 and its implications for thrombosis and anticoagulationJean M Connors, Jerrold H Levy
The New England Journal of Medicine|August 26, 2021
Heparin Resistance - Clinical Perspectives and Management StrategiesJerrold H Levy, Jean M Connors
Pageof 98